AbbVie ABBV has successfully navigated the loss of exclusivity (LOE) for its flagship drug, Humira, by launching two newer ...

We came across a bullish thesis on AbbVie Inc. on Dividend Talks’s Substack. In this article, we will summarize the bulls’ ...

Learn how long it takes for Rinvoq to be cleared from your body, factors that could affect how it’s metabolized, and more.

Healthcare giants AbbVie and Abbott Laboratories are both Dividend Kings. They should maintain their dividend growth habits ...

Rinvoq is a prescription drug used to treat rheumatoid arthritis and other conditions. Learn how to find savings, lower your drug costs, and more.

This Big Pharma stock is one of the safest bets, according to the Mad Money host, and it plays an attractive dividend to shareholders.

Rinvoq is a brand-name drug used to treat certain autoimmune conditions. Discover drug interactions in depth, Rinvoq and alcohol, and more.

NORTH CHICAGO, Ill., April 29, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the U.S. Food and Drug Administration (FDA) has approved RINVOQ® (upadacitinib), 15 mg, once daily, for the ...

AbbVie said on Monday it would acquire privately held cell therapy developer Capstan Therapeutics in a deal worth up to $2.1 ...

AbbVie (NYSE: ABBV) today announced the U.S. Food and Drug Administration (FDA) has approved RINVOQ® (upadacitinib), 15 mg, once daily, for the treatment of adults with giant cell arteritis (GCA ...